FR2859220B1 - Promoteur du gene humain fatp 5 et utilisations - Google Patents

Promoteur du gene humain fatp 5 et utilisations

Info

Publication number
FR2859220B1
FR2859220B1 FR0310224A FR0310224A FR2859220B1 FR 2859220 B1 FR2859220 B1 FR 2859220B1 FR 0310224 A FR0310224 A FR 0310224A FR 0310224 A FR0310224 A FR 0310224A FR 2859220 B1 FR2859220 B1 FR 2859220B1
Authority
FR
France
Prior art keywords
fatp
promoter
human gene
gene
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0310224A
Other languages
English (en)
Other versions
FR2859220A1 (fr
Inventor
Philippe Durbin
Herve Dupont
Maryam Asfari
Genevieve Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
Merck Sante SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0310224A priority Critical patent/FR2859220B1/fr
Application filed by Merck Sante SAS filed Critical Merck Sante SAS
Priority to JP2006524261A priority patent/JP2007533293A/ja
Priority to CA002536866A priority patent/CA2536866A1/fr
Priority to US10/569,795 priority patent/US20070105115A1/en
Priority to EP04741367A priority patent/EP1658310A1/fr
Priority to AU2004268754A priority patent/AU2004268754B2/en
Priority to PCT/EP2004/008747 priority patent/WO2005021590A1/fr
Priority to ARP040103090A priority patent/AR045521A1/es
Publication of FR2859220A1 publication Critical patent/FR2859220A1/fr
Application granted granted Critical
Publication of FR2859220B1 publication Critical patent/FR2859220B1/fr
Priority to JP2011080349A priority patent/JP2011152144A/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
FR0310224A 2003-08-27 2003-08-27 Promoteur du gene humain fatp 5 et utilisations Expired - Fee Related FR2859220B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0310224A FR2859220B1 (fr) 2003-08-27 2003-08-27 Promoteur du gene humain fatp 5 et utilisations
CA002536866A CA2536866A1 (fr) 2003-08-27 2004-08-04 Promoteur du gene humain de fatp5 et utilisations
US10/569,795 US20070105115A1 (en) 2003-08-27 2004-08-04 Promoter of the human fatp5 gene and uses
EP04741367A EP1658310A1 (fr) 2003-08-27 2004-08-04 Promoteur du gene humain de fatp5 et utilisations
JP2006524261A JP2007533293A (ja) 2003-08-27 2004-08-04 ヒトｆａｔｐ５遺伝子のプロモーターおよび使用
AU2004268754A AU2004268754B2 (en) 2003-08-27 2004-08-04 Promoter of the human FATP5 gene and uses
PCT/EP2004/008747 WO2005021590A1 (fr) 2003-08-27 2004-08-04 Promoteur du gene humain de fatp5 et utilisations
ARP040103090A AR045521A1 (es) 2003-08-27 2004-08-27 Promotor del gen de fatp5 humano y usos
JP2011080349A JP2011152144A (ja) 2003-08-27 2011-03-31 ヒトｆａｔｐ５遺伝子のプロモーターおよび使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0310224A FR2859220B1 (fr) 2003-08-27 2003-08-27 Promoteur du gene humain fatp 5 et utilisations

Publications (2)

Publication Number Publication Date
FR2859220A1 FR2859220A1 (fr) 2005-03-04
FR2859220B1 true FR2859220B1 (fr) 2007-10-19

Family

ID=34130619

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0310224A Expired - Fee Related FR2859220B1 (fr) 2003-08-27 2003-08-27 Promoteur du gene humain fatp 5 et utilisations

Country Status (8)

Country Link
US (1) US20070105115A1 (fr)
EP (1) EP1658310A1 (fr)
JP (2) JP2007533293A (fr)
AR (1) AR045521A1 (fr)
AU (1) AU2004268754B2 (fr)
CA (1) CA2536866A1 (fr)
FR (1) FR2859220B1 (fr)
WO (1) WO2005021590A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030232363A1 (en) * 1998-01-15 2003-12-18 Andreas Stahl Fatty acid transport proteins
WO1999051740A2 (fr) * 1998-04-06 1999-10-14 Janssen Pharmaceutica N.V. Sequence de nucleotides exprimant la proteine humaine de transport d'acides gras et sequence correspondante d'acides amines. utilisation pour reguler le metabolisme des acides gras
WO2001021795A2 (fr) * 1999-09-23 2001-03-29 Whitehead Institute For Biomedical Research Proteines de transport d'acides gras
CA2382165A1 (fr) * 1999-12-08 2001-06-14 Genset S.A. Adnc humains pleine longueur codant pour des proteines potentiellement secretees
WO2003044159A2 (fr) * 2001-11-20 2003-05-30 Prochon Biotech Ltd. Proteines a doigts de zinc, polynucleotides codant pour celles-ci et anticorps associes

Also Published As

Publication number Publication date
EP1658310A1 (fr) 2006-05-24
AR045521A1 (es) 2005-11-02
WO2005021590A1 (fr) 2005-03-10
US20070105115A1 (en) 2007-05-10
JP2011152144A (ja) 2011-08-11
CA2536866A1 (fr) 2005-03-10
AU2004268754A1 (en) 2005-03-10
JP2007533293A (ja) 2007-11-22
AU2004268754B2 (en) 2011-05-12
FR2859220A1 (fr) 2005-03-04

Similar Documents

Publication Publication Date Title
DE60106599D1 (de) Substituierte phenylacetamide und ihre verwendung als glukokinase aktivatoren
DE602004012969D1 (de) Phenylacetamide und ihre verwendung als glukokinase-modulatoren
ATE443149T1 (de) Mais metallothionen promoter 2 und methoden zur verwendung
CY2016035I2 (el) Θεραπευτικη χρηση αντισωματων anti-cs1
DE60309856D1 (de) Substituierte phenylacetamide und deren verwendung als glucokinaseaktivatoren
NO20041872L (no) Esterforbindelser og medisinsk anvendelse derav
NO20044916L (no) Preparater av sulfinylacetamid
DE60327254D1 (de) Den getreideertrag erhöhendes gen und dessen nutzung
DE602005015486D1 (de) Esterderivate von ascorbinsäure und 2-ketosäuresacchariden
EP1507826A4 (fr) Amelioration de l'evolution des cataractes et d'autres maladies ophtalmiques
DK1558595T3 (da) Piperazinyl- og diazapanylbenzamider og -benzthioamider
DE60325967D1 (de) Stimulierung von hämatopoiese bei ex vivo aktivierten immunzellen
AU2003277215A1 (en) Novel neurokinin antagonists and methods of use thereof
ITRM20020629A1 (it) Uso di acidi alfa-feniltiocarbossilici e alfa-fenilossicarbossilici ad attivita' ipoglicemizzante e/o ipolipidemizzante.
DE60238174D1 (de) Fluoropolymere und Herstellungs- und Verwendungsverfahren
DE60318819D1 (de) Hitzestabile mutanten von stärkebiosyntheseenzymen
FR2859220B1 (fr) Promoteur du gene humain fatp 5 et utilisations
DE602004022046D1 (de) Herstellung von kleinen teilchen
DE502005004188D1 (en) Carbodiimide mit thiocarbamids ureestergruppen
ITVI20020019A1 (it) Sedia elettrostatica
FI20020360A0 (fi) Biologisesti aktiivisen tuotteen uusi käyttö
AU2003256289A8 (en) Modified shine-dalgarno sequences and methods of use thereof
DE50306263D1 (de) Detektion von toxischen algen
ITMI20041962A1 (it) "peptide di angiostatina e suoi impieghio terapeutici"
JP2003119489A5 (ja) 香料成分としての第三アルコールまたはエステルの使用

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140430